Skip to main content

Find Clinical Trials

Home
Conditions
HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma

Clinical trial condition

HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma

Explore clinical trials studying HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma. Study availability and eligibility vary by location and protocol.

2 public trials 1 recruiting study

Refine in advanced search Browse all conditions

HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma trial results

Recruiting

SHR-A1811 for Subjects With Her2-positive Gastric Cancer and Gastroesophageal Junction Adenocarcinoma After Progression on or After First-line Anti-HER2 Therapy-containing Regimen

NCT06123494

Conditions: HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
Locations: Shanghai East Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

A Real-World, Single-Arm Study Protocol of Disitamab Vedotin in Combination With Immunotherapy and Multimodal Radiation Therapy for HER2-Positive Advanced Gastric Cancer: After Second-Line Treatment Failure

NCT07490990

Conditions: HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
Locations: Not specified

View Trial Details